Teriflunomide and Regurgitation - a phase IV clinical study of FDA data
Regurgitation is reported only by a few people who take Teriflunomide.
The phase IV clinical study analyzes which people take Teriflunomide and have Regurgitation. It is created by eHealthMe based on reports of 4,174 people who have side effects while taking Teriflunomide from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
4,174 people reported to have side effects when taking Teriflunomide.
Among them, 2 people (0.05%) have Regurgitation.
What is Teriflunomide?
Teriflunomide has active ingredients of teriflunomide. eHealthMe is studying from 3,422 Teriflunomide users for its effectiveness, alternative drugs and more.
What is Regurgitation?
Regurgitation (expulsion of material) is found to be associated with 778 drugs and 576 conditions by eHealthMe.
Number of Teriflunomide and Regurgitation reports submitted per year:
Gender of people who have Regurgitation when taking Teriflunomide *:
- female: 100 %
- male: 0.0 %
Age of people who have Regurgitation when taking Teriflunomide *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 50 %
- 60+: 50 %
Common drugs people take besides Teriflunomide *:
- Vitamin C: 1 person, 50.00%
- Protopic: 1 person, 50.00%
Common side effects people have besides Regurgitation *:
- Diarrhea: 2 people, 100.00%
- Visual Impairment: 1 person, 50.00%
- Urinary Incontinence (inability to control the flow of urine and involuntary urination): 1 person, 50.00%
- Abnormal Faeces (abnormal stool): 1 person, 50.00%
- Ageusia (loss of taste functions of the tongue): 1 person, 50.00%
- Belching (release of gas from the digestive tract): 1 person, 50.00%
- Chest Pain: 1 person, 50.00%
- Constipation: 1 person, 50.00%
- Dehydration (dryness resulting from the removal of water): 1 person, 50.00%
- Dyschezia (difficulty in defecating): 1 person, 50.00%
Common conditions people have *:
- Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 50.00%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 50.00%
* Approximation only. Some reports may have incomplete information.
Do you take Teriflunomide and have Regurgitation?Check whether Regurgitation is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Regurgitation and when was it recovered:
Expand to all the drugs that have ingredients of teriflunomide:
Alternative drugs to, pros and cons of Teriflunomide:
- Teriflunomide (3,422 reports)
Common Teriflunomide side effects:
Browse all side effects of Teriflunomide:a b c d e f g h i j k l m n o p q r s t u v w x y z
Regurgitation treatments and more:
- Regurgitation (3,138 reports)
COVID vaccines that are related to Regurgitation:
- Regurgitation in Moderna COVID Vaccine
- Regurgitation in Pfizer BioNTech Covid Vaccine
- Regurgitation in Johnson and Johnson Covid Vaccine
Common drugs associated with Regurgitation:
- Aspirin: 162 reports
- Furosemide: 105 reports
- Metformin: 123 reports
- Nexium: 560 reports
- Omeprazole: 144 reports
- Prilosec: 175 reports
All the drugs that are associated with Regurgitation:
- Regurgitation (779 drugs)
Common conditions associated with Regurgitation:
All the conditions that are associated with Regurgitation:
- Regurgitation (576 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on teriflunomide (the active ingredients of Teriflunomide) and Teriflunomide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Omeprazole and Hepatitis C Positive - a second ago
- Gabitril and Gastric Disorder - 2 seconds ago
- Janumet Xr and Cataract - 15 seconds ago
- Temovate and Liver Disorder - 22 seconds ago
- Viracept and Right Ventricular Systolic Pressure Increased - 24 seconds ago
- Vivelle-Dot and Tendon Injury - 26 seconds ago
- Lozol and Itching - 30 seconds ago
- Cleocin T and Bedridden - 41 seconds ago
- Provera and Vicodin drug interaction - 43 seconds ago
- Sudafed and Colazal drug interaction - 46 seconds ago